CathWorks FFRangio: from clinical data to advanced patient care

Sponsored by Medtronic

Anchorperson: R. Al-Lamee

Spokesperson: B. Honton

Summary

Explore the clinical value of the CathWorks FFRangio system through the lens of the ALL-RISE randomised controlled trial and its implications for daily practice. By reviewing the trial’s primary and secondary endpoints, examine how FFRangio may influence diagnostic assessment, treatment planning, and clinical decision-making in patients undergoing coronary evaluation.

The programme also highlights the practical integration of FFRangio into routine workflows, illustrating how physiology-guided strategies can support more informed therapeutic choices and potentially improve patient management.

Particular attention is given to the anticipated impact of ALL-RISE on future clinical practice and the evolving role of angiography-derived physiology in contemporary interventional cardiology.

Learning Objectives

To learn from the primary and secondary endpoints of the large ALL-RISE randomised controlled trial
To understand how FFRangio can transform your clinical approach
To examine the practical use of FFRangio in everyday clinical settings

Speaker

B. Honton

The practical use of FFRangio in everyday clinical settings

Download presentation

Learn from the primary and secondary endpoints of the large ALL-RISE randomised controlled trial